Like the Norse goddess Idun, who kept the gods os Asgård young and healthy with her golden apples, our vision is to assist people in achieving a healthier lifestyle when diet and exercise are not enough.
We are developing a first-in-class RNA therapy targeting a novel target, glycerol-3-phosphate phosphatase (G3PP), for a healthier weight loss & multi-organ benefits.
Company highlights:
• First-in-class target (G3PP).
• Differentiated MoA beyond existing obesity therapies.
• GWAS validation & in vivo POC.
• RNA platform with infrequent dosing.
• Large and growing obesity market.
• Potential application in multiple TAs beyond obesity.